Breaking News
Get 40% Off 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

Mesoblast Ltd (MEOBF)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
0.600 +0.000    +0.00%
- Delayed Data. Currency in USD ( Disclaimer )
  • Volume: 0
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 0.600 - 0.600
Type:  Equity
Market:  United States
Mesoblast 0.600 +0.000 +0.00%

MEOBF Share Price Overview

 
Assess today's live Mesoblast Ltd (MSB) share price, performance and insights using our live Sydney: MSB stock exchange data.

Analyse the historical data and Mesoblast Ltd share price performance charts on this page. Our technical summary section provides analysis on Mesoblast share price buy/sell indicators using real-time data (or discuss the Mesoblast (MSB) stock price today with other investors in the Mesoblast ASX share price and sentiment chat forum).

Use the dropdown to select a relevant stock exchange for the current ASX MSB share price (ISIN: AU000000MSB8) to enhance your trading decisions with our free investment tools and resources.

What Is the Mesoblast Ltd Share Price Today?
The Mesoblast share price today is 0.600.

What Is the Stock Symbol for Mesoblast Ltd
The stock symbol (or 'ticker') for Mesoblast Ltd is "MSB."

What Stock Exchange Does Mesoblast Ltd Trade On?
Mesoblast Ltd is listed and trades on the Sydney stock exchange.

Is Mesoblast Ltd a Good Stock to Buy?
Determining whether Mesoblast Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Loading
Last Update:
  • 1 Day
  • 1 Week
  • 1 Month
  • 3 Months
  • 6 Months
  • 1 Year
  • 5 years
  • Max
Prev. Close0.43
Day's Range0.6 - 0.6
Revenue7.47M
Open0.6
52 wk Range0.1 - 1
EPS - 0.092
VolumeN/A
Market Cap560.5M
Dividend (Yield)0 (N/A)
Average Volume (3m)359,935
P/E Ratio - 5.35
Beta2.48
1-Year Change - 18.92%
Shares Outstanding1,141,241,211
Next Earnings DateMay 29, 2024
What is your sentiment on Mesoblast?
or
Vote to see community's results!

Technical Summary

Type 5 Min 15 Min Hourly Daily Monthly
Moving Averages Buy Buy Neutral Neutral Sell
Technical Indicators BUY BUY Strong Buy BUY Strong Buy
Summary Buy Buy Buy Neutral Neutral

Candlestick Patterns

 

Filter Table By:

Candle Sticks Characteristics:

Time Frame
Type
Pattern Indication
Reliability
Pattern Timeframe Reliability Candles Ago Candle Time
Emerging Patterns
Three Inside Up 1H Current
Three Inside Up 5H Current
Three Inside Up 1D Current
Three Inside Up 1W Current
Completed Patterns
Tri-Star Bearish 15 1 Mar 28, 2024 18:15
Tri-Star Bullish 1M 4 Nov 23
Tri-Star Bullish 30 7 Nov 24, 2023 14:30

Mesoblast Ltd Quotes

Exchange Last Bid Ask Volume Change % Currency Time
  Sydney 0.765 0.760 0.775 6,203,446 -1.29% AUD  
  NASDAQ 5.200 0.000 0.000 82,471 +1.76% USD  
  OTC Markets 0.600 0.000 0.000 0 +0.00% USD  

Trending Stocks

Create Alert
Add to Watchlist
Add to/Remove from a Portfolio  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

  Name Last High Low Chg. Chg. % Vol. Time
  IAG 168.86 170.10 162.15 -0.94 -0.55% 17.34M 16:14:30  
  Rolls-Royce Holdings 395.70 399.00 391.20 -6.80 -1.69% 13.31M 16:14:06  
  EasyJet 533.35 536.00 514.57 +3.35 +0.63% 1.80M 16:13:58  
  BP 515.20 516.01 504.60 +2.80 +0.55% 18.92M 16:14:39  
  Lloyds Banking 51.06 51.08 50.20 +0.04 +0.08% 69.57M 16:14:27  
  Ocado 347.90 349.40 340.00 -2.10 -0.60% 1.09M 16:14:07  
  HSBC 647.00 647.50 633.80 +2.40 +0.37% 11.10M 16:14:30  
  Barclays 185.60 185.90 181.50 +1.62 +0.88% 27.51M 16:14:11  
  BAE Systems 1,296.75 1,306.00 1,280.50 +9.75 +0.76% 3.95M 16:14:15  
  Wizz Air Holdings PLC 2,120.0 2,128.0 2,015.0 +2.0 +0.09% 115.67K 16:12:34  

%SHORT_NAME% Company Profile

IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

77

Equity Type

ORD

Mesoblast Limited engages in the development of regenerative medicine products in Australia, the United States, Singapore, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its proprietary regenerative medicine technology platform is based on specialized cells known as mesenchymal lineage cells. The company offers Remestemcel-L that is in Phase III clinical trials for the treatment of systemic inflammatory diseases, including steroid refractory acute graft versus host disease, acute respiratory distress syndrome, and biologic refractory inflammatory bowel disease; and Remestemcel-L, which is in Phase III clinical trials to treat chronic heart failure and chronic low back pain due to degenerative disc disease. It is also developing MPC-300-IV to treat biologic refractory rheumatoid arthritis diabetic nephropathy; and MPC-25-IC for the treatment or prevention of acute myocardial infarction. It has strategic partnerships with Tasly Pharmaceutical Group to offer MPC-150-IM for heart failure and MPC-25-IC for heart attacks in China; JCR Pharmaceuticals Co. Ltd. to treat wound healing in patients with epidermolysis bullosa; and Grünenthal to develops and commercializes cell therapy for the treatment of chronic low back pain. The company was incorporated in 2004 and is headquartered in Melbourne, Australia.

Read More
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

MSB Price Commentary

Write your thoughts about Mesoblast Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email